A Simple Blinding Index for Randomized Controlled Trials
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Blinding is an essential part of many randomized controlled trials. However, its quality is usually not checked, and when it is, common measures are the James index and/or the Bang index. In the present paper we discuss these two indices, providing examples demonstrating their considerable weaknesses and limitations, and propose an alternative method for measuring blinding. We argue that this new approach has a number of advantages. We also provide an R-package for computing our blinding index.
References
1.
Takakura N, Yajima H
. A double-blind placebo needle for acupuncture research. BMC Complement Altern Med. 2007; 7:31.
PMC: 2176062.
DOI: 10.1186/1472-6882-7-31.
View
2.
Zaslawski C, Rogers C, Garvey M, Ryan D, Yang C, Zhang S
. Strategies to maintain the credibility of sham acupuncture used as a control treatment in clinical trials. J Altern Complement Med. 1998; 3(3):257-66.
DOI: 10.1089/acm.1997.3.257.
View
3.
Shin M, Kim J, Lee M, Kim K, Choi J, Kang K
. Acupuncture for treating dry eye: a randomized placebo-controlled trial. Acta Ophthalmol. 2010; 88(8):e328-33.
DOI: 10.1111/j.1755-3768.2010.02027.x.
View
4.
Hemila H
. Assessment of blinding may be inappropriate after the trial. Contemp Clin Trials. 2005; 26(4):512-4.
DOI: 10.1016/j.cct.2005.04.002.
View
5.
Al-Lamee R, Thompson D, Dehbi H, Sen S, Tang K, Davies J
. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. Lancet. 2017; 391(10115):31-40.
DOI: 10.1016/S0140-6736(17)32714-9.
View